We Need New Agents For SCLC by Dr. Kalemkerian - Overview of Some Candidates Includes Lurbinectedin, Nal-iri, APG-1252 But Lack of Biomarkers Remains an Impediment. How do The Negative ATLANTIS Results Impact Lurbi Use? Need to See The Full Data to Interpret .